CClinicalTrials.gg
CompletedNCT05548920SVC IVC CIUpdated Jan 18, 2023

Preoperative Ultrasound Guided Evaluation of SVC-CI and IVC -CI as Predictors of Hypotension After Induction of Anaesthesia in Major Onco-surgery

An observational study in Total Fluid Volume Decreased, sponsored by Rajiv Gandhi Cancer Institute & Research Center, India. Completed at 1 site in India. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2023-01-18.

Sponsored by Rajiv Gandhi Cancer Institute & Research Center, India · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
120
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Patients undergoing major Oncosurgeries are fluid deficit due to preoperative fasting , inadequate intake due to disease hence prone to development of hypotension after induction of general anaesthesia owing to vasodilatory effects of anesthetic induction agents. Investigators plan study to measure ultrasound guided Superior Vena Cava and Inferior Vena Cava collapsibility Index as predictors of hypotension after induction of General anaesthesia.

Read the detailed description

Investigators plan prospective study , written informed will be taken from all included patients. In the OR 5 lead ECG, NIBP,SPO2 monitors will be attached , patients will be explained about Ultrasound imaging . Preinduction using SONOSITE EDGE II ultrasonography machine and placing high frequency linear array probe (6-13 Hz) beneath the middle of the clavicle aligned in deltopectoral groove to obtain short axis view of Subclavian/Infraclavicular axillary vein in B-Mode (2-D imaging). Doppler pulse waveform and minimum and maximum diameter measurements of SVC will be obtained in M-mode , both during spontaneous breathing and after deep inspiration, using digital calipers after freezing the image. The collapsibility index CI will be calculated using the following equation SCV AV CI = (dSCV max- dSCV min)/ dSCV max ×100.

A phased array or cardiac ultrasound probe (1-5Hz) will be placed in the subxiphoid window to view IVC at the junction of IVC with right atrium .Then the transducer will be adjusted to obtain the long axis view of IVC. Doppler pulse waveform will be obtained to ensure imaging of IVC and then in the M mode the minimum and maximum diameter measurements of IVC will be obtained both during spontaneous breathing and after deep inspiration, using digital calipers after freezing the image. The collapsibility index CI will calculated using the following equation:IVC CI = (dIVCmax- dIVCmin )/ dIVCmax ×100 . In all the patients both SVC and IVC -CI will be calculated.

All patients will receive standard General Anesthesia with IV Fentanyl 1-2 mcg/kg , Sleeping dose propofol , Atracurium 0.5mg/kg and orally placed Endotracheal tube.The heart rate (HR) and mean arterial pressure (MAP) will be recorded in two phases .Intraoperative hypotension (IOH) been defined as MAP\<60mmHg or >30%decrease in MAP from baseline.

  1. Post induction phase: Readings will be taken at 1 min intervals from the start of induction till intubation (upto 5 minutes) and
  2. Post intubation phase: Readings will be taken at 2 min intervals upto 10 min and at 5 min intervals up to 30 mins or till incision . Each hypotensive episode encountered will be treated with leg lifting first (lifting both lower extremities for 2 minutes by technical staff) , if hypotension persists then IV Ephedrine 6 mg boluses will be given . All patients will receive preloading 200ml crystalloids prior to induction of anesthesia .
02

Conditions studied

  • Total Fluid Volume Decreased

Browse trials for

03

In context

Hypotension

1,003 studies on the registry are indexed under Hypotension; 173 are open to participants now.

This study's enrollment of 120 is above the median of 84 across 294 observational studies indexed under Hypotension.

Browse Hypotension studies →

Lead sponsor

Rajiv Gandhi Cancer Institute & Research Center, India is the lead sponsor of 25 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients undergoing major Onco-surgeries.

Inclusion criteria

  • Patients belonging to ASA Grade I,II,III
  • For major Oncosurgery under general anaesthesia

Exclusion criteria

Exclusion Criteria:

  • Patient refusal
  • BMI>30
  • Emergency surgery
  • Preoperative Hypotension MAP \< 70 mmHg
  • LVEF\<40%
  • Difficult Airway
  • Nasal Intubation
  • Inability to obtain good ultrasound images of SCV and IVC .
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
120 participants (actual)
Patient registry
No

Groups and cohorts

  • Ultrasound guided Superior Vena Cava Collapsibility Index (SVC - CI)

    Preoperative ultrasound guided Superior Vena Cava collapsibility Index will be measured with patient breathing spontaneously and on deep inspiration.

    Other: Ultrasound guided Superior Vena Cava Collapsibility Index

  • Ultrasound Guided Inferior Vena Cava Collapsibility Index (IVC -CI)

    Preoperative Ultrasound guided Inferior Vena Cava collapsibility Index will be measured with patient breathing spontaneously and on deep inspiration.

    Other: Inferior Vena Cava Collapsibility Index

Interventions

  • OtherUltrasound guided Superior Vena Cava Collapsibility Index

    Preoperative Ultrasound guided Superior Vena Cava Collapsibility Index will be measured

  • OtherInferior Vena Cava Collapsibility Index

    Preoperative Inferior Vena Cava Collapsibility Index will be measured.

06

What researchers measure

Primary outcomes

  1. To compare Subclavian Vein Collapsibility Index in percentage with Inferior Vena Cava Collapsibility Index in percentage as predictor of hypotension after induction of General anaesthesia

    Preoperative Ultrasound guided Subclavian / Infraclavicular Axillary Vein Collapsibility Index and Inferior Vena Cava Collapsibility Index was measured with spontaneous breathing and on deep inspiration.

    Time frame: 30 minutes prior to induction of anaesthesia

Secondary outcomes

  1. To evaluate the sensitivity of SVC -CI and IVC -CI as a predictor of hypotension after induction of General anesthesia .

    Preoperative US Guided SVC-CI in percentage and IVC -CI in percentage values will be obtained and statistical analysis will be done

    Time frame: 30 minutes prior to induction of anaesthesia

07

Study locations

1 site
  • Rajiv Gandhi Cancer Institute and Research Centre
    New Delhi, Delhi 110085, India
08

References and documents

Publications

  • Choi MH, Chae JS, Lee HJ, Woo JH. Pre-anaesthesia ultrasonography of the subclavian/infraclavicular axillary vein for predicting hypotension after inducing general anaesthesia: A prospective observational study. Eur J Anaesthesiol. 2020 Jun;37(6):474-481. doi: 10.1097/EJA.0000000000001192. PubMed 32205573 ↗
  • Kaptein YE, Kaptein EM. Comparison of subclavian vein to inferior vena cava collapsibility by ultrasound in acute heart failure: A pilot study. Clin Cardiol. 2022 Jan;45(1):51-59. doi: 10.1002/clc.23758. Epub 2021 Dec 21. PubMed 34931333 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 18, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05548920
Lead sponsor
Rajiv Gandhi Cancer Institute & Research Center, India
Responsible party
Dr Anita Kulkarni (Senior Consultant, Rajiv Gandhi Cancer Institute & Research Center, India) — Principal investigator
First posted
Sep 22, 2022
Start date
Jun 26, 2021
Primary completion
Dec 30, 2022
Completion
Jan 10, 2023
Last update
Jan 18, 2023

Study contacts

Anita C Kulkarni, MD
principal investigator · Senior Consultant

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion